Temprian Therapeutics
Sumeet Dagar, PhD, MBA is an experienced professional who currently serves as the Chief Executive Officer at Temprian Therapeutics and as the Founder and Principal at Effector Life Science. With a background in pharmacy and biotechnology management, Sumeet has held various leadership positions in companies such as Xellia Pharmaceuticals and Akorn, Inc. Sumeet has also contributed to academia as an Adjunct Assistant Professor at the University of Illinois at Chicago. With a diverse career in the pharmaceutical and biotechnology industry, Sumeet brings a wealth of knowledge and expertise to the organizations Sumeet is involved in.
This person is not in any teams
Temprian Therapeutics
Temprian Therapeutics is a developer of therapies intended for autoimmune disease. The company offers DNA-based treatment by injecting DNA coding for a modified heat shock protein to stop the autoimmune response at the outset, enabling consumers to get treatments for vitiligo disease.